There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

The pharma industry's dogged determination to develop amyloid-targeting therapies for Alzheimer's disease is a "road to nowhere", according to the scientist behind a rival approach. Claude Wischik ...

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

A recent study revealed that an experimental blood test for Alzheimer’s disease not only can help in accurate diagnosis but ...

At high levels of brain amyloid-beta, women had more aggressive tau accumulation than men, a meta-analysis of longitudinal PET data showed. In cognitively normal people with high baseline amyloid ...

Encouraging interim results have supported Roche’s decision to move trontinemab into a pivotal Phase III programme.